Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma
Stay Informed – Subscribe to latest updates. We promise to send only relevant and valuable emails, just insights you care about!
Safety, Tolerability, and Preliminary Efficacy of JBZ-001 in Patients with Advanced Solid Tumors and Non-Hodgkin Lymphoma
theminingnews.com is owned by Mining Investor Resources Media Ltd. © 2025 Mining Investor Resources Media Ltd.
All rights reserved.